LIVN
LIVN
NASDAQ · Health Care

Livanova Plc

$71.86
+0.94 (+1.32%)
As of May 9, 1:23 AM ET ·
Financial Highlights (FY 2026)
Revenue
1.40B
Net Income
-244,185,091
Gross Margin
67.7%
Profit Margin
-17.5%
Rev Growth
+10.8%
D/E Ratio
0.31
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 67.7% 67.7% 56.7% 56.7%
Operating Margin 14.1% 12.7% 20.0% 18.3%
Profit Margin -17.5% -16.6% 16.6% 15.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.40B 1.26B 866.49M 838.17M
Gross Profit 946.50M 854.62M 491.05M 475.01M
Operating Income 196.96M 160.06M 173.09M 153.62M
Net Income -244,185,091 -198,434,836 144.22M 131.68M
Gross Margin 67.7% 67.7% 56.7% 56.7%
Operating Margin 14.1% 12.7% 20.0% 18.3%
Profit Margin -17.5% -16.6% 16.6% 15.7%
Rev Growth +10.8% +10.8% +3.7% +6.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 471.55M 471.55M 1.67B 1.31B
Total Equity 1.50B 1.50B 2.65B 2.44B
D/E Ratio 0.31 0.31 0.63 0.54
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -137,537,111 -117,977,657 227.62M 227.59M
Free Cash Flow 128.87M 109.61M